Recent developments regarding another win for wegovy: fda approves higher semaglutide dose as part of new pilot program – cardiovascular business have draw
FDA approves oral Wegovy pill, offering needle-free GLP-1 option for weight management alongside existing injection therapy.
Influencers promote peptides for wellness, but NPR finds scientific evidence lags far behind the social media hype and claims.
FDA approves high-dose Wegovy, expanding Novo Nordisk’s obesity treatment options amid surging demand for GLP-1 medications.
Allergan launches BOTOX® Cosmetic for masseter muscle reduction in China, offering non-surgical jawline contouring.
Deer antler stem cell exosomes show promise for regenerative medicine, harnessing nature’s fastest-growing tissue for human therapy.
Sermorelin.com introduces peptide therapy program targeting patients on GLP-1 medications for weight management and metabolic health.
New Axios-Ipsos polling shows Americans are accessing GLP-1 medications despite high costs, with perceived health benefits outweighing financial concerns.
Exosome therapy shows promise in reconstructive surgery by enhancing tissue healing, reducing scarring, and improving graft survival rates.
Research suggests testosterone therapy may address specific perimenopausal symptoms, though experts emphasize careful evaluation and monitoring are essenti